News

SGLT-2 inhibitors are now recommended as first-line therapy for people with type 2 diabetes who have had a previous cardiovascular event. However, there are concerns over a few safety issues associated with ...

Modern lifestyles tend to preclude a prolonged fast during the night, with food being consumed over a long time period, which may have a detrimental effect on metabolic health. A new study, reported in a rec...

In a welcome return for ‘The briefing room’, a group of diabetes research luminaries examine the rise to prominence of medications that work by stimulating receptors for GIP and GLP-1 –&nbs...

In a new series of films on Horizons, leading researchers and clinicians from around the world talk about the journal articles that have left a deep impression on their understanding and practice in the fiel...

A new review, reported in a recent issue of Diabetologia, looks at glycaemic thresholds for the appearance of the signs and symptoms of hypoglycaemia in people with and without type 1 diabetes. These appear ...

Previous research has shown that both type 1 and type 2 diabetes are associated with increased morbidity and mortality from COVID-19 infection. However, we don’t know if this increased risk arises from...

Revealing the transcriptome of each pancreatic islet cell type could take us a long way towards clarifying the underlying mechanisms of type 2 diabetes. Single-cell RNA sequencing offers this level of geneti...

Obstructive sleep apnoea, with its various health consequences, is more common among people with type 2 diabetes than those without the condition. A new study, reported in a recent issue of Diabetologia, fin...

A new study in a recent issue of Diabetologia compares intermittent (flash) glucose monitoring with finger-prick testing in a group of pregnant women with type 1 diabetes. While flash did improve glycaemic c...

Tirzepatide is a new class of drug for management of type 2 diabetes. A meta-analysis of its glucose-lowering and weight-loss effects, presented in a recent issue of Diabetologia, will help guide treatment d...

A new analysis of the Global Burden of Disease study, presented in a recent issue of Diabetologia, reveals the geographical variation of type 2 diabetes and how risk factors for the associated morbidity and ...

Insulin allergy can cause significant challenges in diabetes treatment. A new paper in Diabetologia discusses the diagnosis and management of this rare, but important, condition. Dr Susan Aldridge reports.

For the latest in our series ‘The long and the short of it’, renowned psychologists with a specialism in diabetes, Professors Bill Polonsky (University of California, USA) and Frank Snoek (Amster...

A new analysis from the Adolescent Cardio-Renal Intervention Trial, reported in a recent issue of Diabetologia, shows that higher urinary albumin/creatinine ratio – even within the normal range –...

A new study, reported in a recent issue of Diabetologia, shows that dapagliflozin benefits people across a wide range of kidney disease severity. The findings, based on an analysis of the DAPA-CKD trial, tak...

Combining data from continuous glucose monitoring with self-care and mental health data could help improve diabetes care. A new review in Diabetologia looks at the emerging area of precision monitoring. Dr S...

In the latest episode of The long and the short of it, professors Larry Fisher and Frank Snoek get to grips with some of the emotional aspects of living with diabetes – focusing on diabetes distress an...

Recent research suggests that pharmacoepigenetics may have clinical relevance in type 2 diabetes, from predicting who will respond to diabetes drugs to developing innovative therapies targeting epigenetic en...

Steroids, antipsychotics, antiretroviral therapy for HIV and immune checkpoint inhibitors against cancer: all of these may cause diabetes. A new review in Diabetologia looks at these four classes of diabetog...

The complications of type 2 diabetes need more attention in primary care. In the latest installment in our series The long and the short of it, we hear about what needs to be looked for, how best to do it an...

If you’ve been following our Insulin in my country series, you might be interested in a commentary on the insulin market – past, present and future – which appears in a recent issue of Diab...